Cansino announced that the company has obtained the “Drug Registration Certificate” for the adsorbed tetanus vaccine issued by the State Drug Administration, and the approval number is Sinopharm Standard S20260063. The vaccine is used to prevent non-neonatal tetanus. Phase III clinical data showed that GMC antibodies were superior to the control vaccine after 30 days of exemption. The company has reached an exclusive commercialization cooperation agreement with Yuanda Life Sciences for this vaccine.

Cansino announced that the company has obtained the “Drug Registration Certificate” for the adsorbed tetanus vaccine issued by the State Drug Administration, and the approval number is Sinopharm Standard S20260063. The vaccine is used to prevent non-neonatal tetanus. Phase III clinical data showed that GMC antibodies were superior to the control vaccine after 30 days of exemption. The company has reached an exclusive commercialization cooperation agreement with Yuanda Life Sciences for this vaccine.